[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@TaxiBiotech TaxiBiotechTaxiBiotech posts on X about $crnx, $mreo, $rzlt, $mbx the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance XXXXX% exchanges XXXX% stocks XXXX%
Social topic influence $crnx 17.65%, $mreo 17.65%, $rzlt 11.76%, $mbx 11.76%, $stim 5.88%, $345m 5.88%, $78m 5.88%, $10m 5.88%, debt 5.88%, $94m XXXX%
Top accounts mentioned or mentioned by @mauriziobruno10
Top assets mentioned Crinetics Pharmaceuticals, Inc. (CRNX) Marblex (MBX) uniQure N.V. (QURE) Synthetify (SNY) Sage Therapeutics, Inc (SAGE) Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Kymera Therapeutics, Inc. Common Stock (KYMR) Terns Pharmaceuticals, Inc. Common Stock (TERN) Denali Therapeutics Inc. Common Stock (DNLI)
Top posts by engagements in the last XX hours
"$STIM (Neuronetics Inc.) Cash: $34.5M (also raised $7.8M via ATM + secured $10M debt tranche) Q3 Net loss: $9.4M Pipeline/updates: Greenbrook clinics revenue up +25% (US $21.8M) driving growth; CEO transition planned for June XX 2026 Next catalysts: Q4 revenue outlook $40M-$43M; full-year guidance $147M-$150M"
X Link 2025-11-05T15:44Z XXX followers, XXX engagements
"02_12_25 Biotech Stock News. Daily Recap. English $VTYX $TLSA $BLTE $SGMO $KURA $XBI"
X Link 2025-12-02T16:06Z XXX followers, XXX engagements
"$RZLT Surprised by the previous data and the final trial result. Were the results a placebo effect XX% placebo effect TA great too. RIP"
X Link 2025-12-11T14:24Z XXX followers, XXX engagements
"12_12_25 🗞🧬 Biotech Stock News. Daily Recap. English It seems like there are no major updates from #NASDAQ BIOTTECH companies TODAY. The most relevant news: Acquisition of Applied Therapeutics ($APLT) by Cycle Pharmaceuticals. The offer: $XXXXX in cash per share and a CVR (Contingent Value Right) subject to future regulatory milestones. A -XX% drop in $APLT since October is a tough blow. I completely understand the pain their investors are feeling"
X Link 2025-12-12T14:37Z XXX followers, XXX engagements
"$ACRS Aclaris Therapeutics Cash: $167M Runway H2 2028 Q325: Net loss $14.6M (vs XXX in 2024) Next milestones: "expect to drive four clinical stage product candidates in 2026" Initiation of Phase X Trial in an Additional Indication Expected in the First Half of 2026 Initiation of Phase 1b Proof-of-Concept Trials of ATI-052 in Asthma and Atopic Dermatitis (AD) Expected in the First Half of 2026"
X Link 2025-11-07T12:14Z XXX followers, XXX engagements
"Updating my Biotech portfolio 🧬📈 Still holding $CRNX. I trust the 2025 catalysts for $MREO. And adding for Q1 2026: $RZLT $OCS $KYTX Used the same method as in my previous video for these new picks. Not investment advice. Do your own R&D"
X Link 2025-11-28T11:37Z XXX followers, 2845 engagements
"$MREO X de X BINGO 💥💥💥🎯"
X Link 2025-12-03T18:10Z XXX followers, XXX engagements
"🎯3/3 with +22% on $MREO 💥"
X Link 2025-12-03T18:13Z XXX followers, XXX engagements
"04_12_25 Biotech Stock News. Daily Recap. English $PLRX $PSTV $QURE $CBIO $SNTI $PPCB $SNY $ENLV"
X Link 2025-12-04T15:31Z XXX followers, XXX engagements
"10_12_25 Biotech Stock News. Daily Recap. English $SAGE $AMRX $FULC $KYMR $TERN $DNLI Sagimet Amneal Fulcrum Kymera Terns Denali"
X Link 2025-12-10T15:15Z XXX followers, XXX engagements
"@mauriziobruno10 They have announced a publication in The Lancet. However they had already presented it at a congress in October. Shares +1% today already known I think"
X Link 2025-12-12T15:27Z XXX followers, XX engagements